| Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer J Bonaventura, G Navarro, V Casadó-Anguera, K Azdad, W Rea, ... Proceedings of the National Academy of Sciences 112 (27), E3609-E3618, 2015 | 175 | 2015 |
| Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase G Navarro, A Cordomí, V Casadó-Anguera, E Moreno, NS Cai, A Cortés, ... Nature communications 9 (1), 1242, 2018 | 130 | 2018 |
| Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and … S Ferré, J Bonaventura, W Zhu, C Hatcher-Solis, J Taura, C Quiroz, ... Frontiers in pharmacology 9, 243, 2018 | 97 | 2018 |
| Pivotal role of adenosine neurotransmission in restless legs syndrome S Ferré, C Quiroz, X Guitart, W Rea, A Seyedian, E Moreno, ... Frontiers in neuroscience 11, 722, 2018 | 87 | 2018 |
| Control of glutamate release by complexes of adenosine and cannabinoid receptors A Köfalvi, E Moreno, A Cordomí, NS Cai, V Fernández-Dueñas, ... BMC biology 18, 1-21, 2020 | 73 | 2020 |
| Opioid–galanin receptor heteromers mediate the dopaminergic effects of opioids NS Cai, C Quiroz, J Bonaventura, A Bonifazi, TO Cole, J Purks, AS Billing, ... The Journal of clinical investigation 129 (7), 2730-2744, 2019 | 54 | 2019 |
| Design of a true bivalent ligand with picomolar binding affinity for a G protein-coupled receptor homodimer D Pulido, V Casadó-Anguera, L Pérez-Benito, E Moreno, A Cordomí, ... Journal of medicinal chemistry 61 (20), 9335-9346, 2018 | 50 | 2018 |
| Evidence for the heterotetrameric structure of the adenosine A2A–dopamine D2 receptor complex V Casadó-Anguera, J Bonaventura, E Moreno, G Navarro, A Cortés, ... Biochemical Society Transactions 44 (2), 595-600, 2016 | 40 | 2016 |
| α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands M Sánchez-Soto, V Casadó-Anguera, H Yano, BJ Bender, NS Cai, ... Molecular neurobiology 55, 8438-8454, 2018 | 31 | 2018 |
| Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer PA De Oliveira, E Moreno, N Casajuana-Martin, V Casadó-Anguera, ... Pharmacological research 182, 106322, 2022 | 23 | 2022 |
| Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer D Pulido, V Casadó-Anguera, M Gómez-Autet, N Llopart, E Moreno, ... Journal of medicinal chemistry 65 (1), 616-632, 2022 | 23 | 2022 |
| Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants S Ferré, AM Belcher, J Bonaventura, C Quiroz, M Sánchez-Soto, ... Frontiers in Endocrinology 13, 1014678, 2022 | 22 | 2022 |
| Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor Variant M Sánchez-Soto, H Yano, NS Cai, V Casadó-Anguera, E Moreno, ... Molecular neurobiology 56, 4778-4785, 2019 | 19 | 2019 |
| Adipose tissue coregulates cognitive function N Oliveras-Cañellas, A Castells-Nobau, L de la Vega-Correa, ... Science advances 9 (32), eadg4017, 2023 | 17 | 2023 |
| What are the current trends in G protein-coupled receptor targeted drug discovery? V Casadó, V Casadó-Anguera Expert opinion on drug discovery 18 (8), 815-820, 2023 | 16 | 2023 |
| Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model V Casado-Anguera, E Moreno, J Mallol, S Ferre, EI Canela, A Cortes, ... Pharmacological research 139, 337-347, 2019 | 16 | 2019 |
| The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome A Cortés, V Casadó-Anguera, E Moreno, V Casadó Advances in pharmacology 84, 37-78, 2019 | 13 | 2019 |
| Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum R Franco, V Casadó-Anguera, A Muñoz, M Petrovic, G Navarro, E Moreno, ... Molecular neurobiology 53, 5436-5445, 2016 | 13 | 2016 |
| Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs V Casadó-Anguera, A Cortés, V Casado, E Moreno Expert opinion on drug discovery 14 (12), 1297-1312, 2019 | 11 | 2019 |
| Unmasking allosteric-binding sites: novel targets for GPCR drug discovery V Casadó-Anguera, V Casadó Expert Opinion on Drug Discovery 17 (8), 897-923, 2022 | 9 | 2022 |